Neurokine Therapeutics
1 clinical trials · Sponsor
◉ Watch Neurokine Therapeutics
| Record | Firm | Date |
|---|---|---|
| MW150 Stress Kinase Inhibitor in Mild to Moderate Alzheimer's Disease (NCT05194163) | Neurokine Therapeutics | 2022-05-01 |
Track Neurokine Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.